Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Blocking RON Shuts Down Breast Cancer Metastasis

By BiotechDaily International staff writers
Posted on 16 Jan 2014
A recent paper suggested that initiation of breast cancer metastasis did not depend on a specific genetic mutation but rather on improper regulation of molecular pathways that control activation and inactivation of certain critical genes.

Investigators at the University of Utah (Salt Lake City, USA) focused their research on the protein product of the RON gene, known as macrophage stimulating 1-receptor (MST1R), a member of the Met family of receptor tyrosine kinases. The biological activity of RON was mediated by binding of its extracellular ligand, macrophage-stimulating protein (MSP), and the protein macrophage stimulating 1 (MST1). Binding of MSP activated RON and led to cellular growth, motility, and invasion. Recent studies have documented RON overexpression in a variety of human cancers including those of the breast, colon, liver, pancreas, and bladder, which often correlate with poor outcome. Moreover, clinical studies have shown that RON overexpression is associated with metastasis and worse patient outcomes.

In the current study, published in the January 2, 2014, online edition of the journal Cell Reports, the investigators showed that the RON/MSP pathway enhanced metastasis of breast cancer xenografts by reprogramming DNA methylation at specific target genes.

RON/MSP-initiated differential-DNA methylation was found to be the result of upregulation of the enzyme MBD4 (methyl-CpG binding domain protein 4), a thymine DNA glycosylase. MBD4 bound specifically to methylated DNA via an MBD domain at the N-terminus that functioned both in binding to methylated DNA and in protein interactions and a C-terminal mismatch-specific glycosylase domain that was involved in DNA repair.

Knockdown of MBD4 in RON/MSP-expressing breast cancer cells or inhibition of the glycosylase catalytic residue of MBD4 reversed the DNA methylation pattern on specific loci and blocked metastasis.

“Genetic mutations do not drive this mechanism,” said senior author Dr. Alana Welm, associate professor of oncological sciences at the University of Utah. “Instead, it is improper regulation of when genes turn on and off. No one has ever described a specific pathway driving this kind of reprogramming in metastasis, much less a way to therapeutically block it. Also, RON has not previously been known to be involved in reprogramming gene expression.”

“If there is an entire program in the tumor cell that is important for metastasis, blocking one small part of that program, for example, the action of a single gene will probably not be an effective strategy,” said Dr. Welm. “But if you could find a way to turn off the entire program, you are more likely to have the desired effect. We found that inhibiting RON turns off the entire metastasis program in these tumor cells.

Related Links:

University of Utah



comments powered by Disqus

Channels

Drug Discovery

view channel

Ibuprofen May Restore Immune Function in Older Individuals

New research suggests that macrophages from the lungs of old mice respond differently to infections than those of young mice, and ibuprofen given to the mice reversed these changes. New research using lab mice suggests that the solution to more youthful immune function might already be a common over-the-counter pain reliever.... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel
Image: Leica Microsystems launches the inverted research microscope platform Leica DMi8 (Photo courtesy of Leica Microsystems).

New Inverted Microscope Designed to Readily Adapt to Changing Research Demands

A new inverted microscope for biotech and other life science laboratories was designed to readily accommodate modifications and upgrades to allow it to keep current with changing research demands and interests.... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.